Literature DB >> 34676028

Protein Degradation Inducers of Androgen Receptor by Conjugation of Antagonists Androgen Receptor and E3 Ligase Ligand.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2021        PMID： 34676028      PMCID： PMC8521611          DOI： 10.1021/acsmedchemlett.1c00468

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  6 in total

Review 1.  PROTACs and Other Chemical Protein Degradation Technologies for the Treatment of Neurodegenerative Disorders.

Authors:  Shusuke Tomoshige; Minoru Ishikawa
Journal:  Angew Chem Int Ed Engl       Date:  2020-08-18       Impact factor: 15.336

Review 2.  PROTACs to address the challenges facing small molecule inhibitors.

Authors:  Pedro Martín-Acosta; Xiangshu Xiao
Journal:  Eur J Med Chem       Date:  2020-11-05       Impact factor: 6.514

Review 3.  Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer.

Authors:  Marzieh Ehsani; Faith Oluwakemi David; Aria Baniahmad
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

Review 4.  Major Advances in Targeted Protein Degradation: PROTACs, LYTACs, and MADTACs.

Authors:  Shanique Alabi; Craig Crews
Journal:  J Biol Chem       Date:  2021-04-08       Impact factor: 5.157

Review 5.  E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points.

Authors:  Aleša Bricelj; Christian Steinebach; Robert Kuchta; Michael Gütschow; Izidor Sosič
Journal:  Front Chem       Date:  2021-07-05       Impact factor: 5.221

Review 6.  Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review.

Authors:  Tae Jin Kim; Young Hwa Lee; Kyo Chul Koo
Journal:  Biomolecules       Date:  2021-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.